You are here

  • Home
  • Archive
  • Volume 62, Issue 12
  • Treatment with infliximab (Remicade) when etanercept (Enbrel) has failed or vice versa: data from the STURE registry showing that switching tumour necrosis factor α blockers can make sense

Article info

Article menu

Download PDFPDF

Extended report
Treatment with infliximab (Remicade) when etanercept (Enbrel) has failed or vice versa: data from the STURE registry showing that switching tumour necrosis factor α blockers can make sense

Authors

  1. Correspondence to:
    Associate Professor R F van Vollenhoven
    Department of Rheumatology, Karolinska Hospital, D2-1, 17176 Stockholm, Sweden; ronald.vanvollenhovenks.se
View Full Text

Citation

van Vollenhoven R, Harju A, Brannemark S, et al
Treatment with infliximab (Remicade) when etanercept (Enbrel) has failed or vice versa: data from the STURE registry showing that switching tumour necrosis factor α blockers can make sense
Annals of the Rheumatic Diseases 2003;62:1195-1198.

Publication history

  • Accepted June 29, 2002
  • First published November 21, 2003.
Online issue publication 
November 21, 2003

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Copyright 2003 by Annals of the Rheumatic Diseases